Bill > AB54

This bill prohibits the Wisconsin Department of Health Services (DHS) from applying utilization management controls (formal techniques used to evaluate the medical necessity, appropriateness, efficacy, or efficiency of prescription drugs) to any antipsychotic medications that have been approved by the federal Food and Drug Administration (FDA). Specifically, the bill creates a new section in Wisconsin statutes that defines prescription drugs and utilization management controls, and then explicitly prevents DHS from implementing prior authorization, step therapy protocols, or other similar management techniques for these specific medications under the Medical Assistance program. This means that patients receiving Medical Assistance (a joint federal and state health program for individuals with limited financial resources) would have more direct access to prescribed antipsychotic medications without additional administrative barriers or review processes that might delay or complicate their treatment.

Health and Social Services

https://docs.legis.wisconsin.gov/2025/proposals/reg/asm/bill/ab54